US 12,064,160 B2
Tattoo removal using a liquid-gas mixture with plasma gas bubbles
James W. Winkelman, Chestnut Hill, MA (US); and Martin E. Schmieg, Delray Beach, FL (US)
Assigned to Clear Intradermal Technologies, Inc., New York, NY (US)
Filed by Clear Intradermal Technologies, Inc., New York, NY (US)
Filed on Nov. 7, 2022, as Appl. No. 17/982,153.
Application 16/902,767 is a division of application No. 15/155,750, filed on May 16, 2016, granted, now 10,716,611, issued on Jul. 21, 2020.
Application 17/982,153 is a continuation of application No. 16/938,694, filed on Jul. 24, 2020, granted, now 11,490,947.
Application 16/938,694 is a continuation in part of application No. 16/902,767, filed on Jun. 16, 2020, granted, now 11,439,453, issued on Sep. 13, 2022.
Application 16/938,694 is a continuation in part of application No. 16/711,549, filed on Dec. 12, 2019, abandoned.
Claims priority of provisional application 62/162,180, filed on May 15, 2015.
Claims priority of provisional application 62/782,208, filed on Dec. 19, 2018.
Prior Publication US 2023/0165622 A1, Jun. 1, 2023
Int. Cl. A61N 1/44 (2006.01); A61B 18/04 (2006.01); A61B 18/14 (2006.01); A61Q 1/14 (2006.01); A61B 17/00 (2006.01); A61B 18/00 (2006.01)
CPC A61B 18/042 (2013.01) [A61B 18/1477 (2013.01); A61Q 1/145 (2013.01); A61B 2017/00769 (2013.01); A61B 2017/00973 (2013.01); A61B 2018/0016 (2013.01); A61B 2018/00166 (2013.01); A61B 2018/00196 (2013.01); A61B 2018/0047 (2013.01); A61B 2018/00583 (2013.01); A61B 2018/00714 (2013.01); A61B 2018/00916 (2013.01); A61B 2218/002 (2013.01); A61B 2218/007 (2013.01); A61N 1/44 (2013.01)] 8 Claims
OG exemplary drawing
 
1. A system for removing a tattoo from a subject's skin, the system comprising:
a gas source for providing a gas,
a liquid source for providing a liquid,
a plasma generator for receiving the gas and liquid and generating an activated liquid-gas mixture comprising the liquid with plasma gas bubbles, and
a conduit for delivery of the activated liquid-gas mixture to a target tattooed region,
a mobilization liquid delivery component for delivering a mobilization liquid either from the liquid source or from an alternative liquid source to the target tattoo region either before, during or after delivery of the activated liquid-gas mixture,
wherein the mobilization liquid delivery component comprises a syringe and a needle for delivery of the mobilization liquid.